Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Some individuals may experience mild gastrointestinal discomfort or bloating
P.ZhangQ.et al (2022)
Cancers 12, 25352611
If any apply, the medication should not be prescribed: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious hypersensitivity to the active medication or to a related incretin-receptor agonist Clinical precautions that prompt careful screening These are not absolute contraindications on the FDA label, but they meaningfully change the risk-benefit conversation
US$ 22.18
US$ 24.38
US$ 25.37
US$ 24.31
US$ 25.46
US$ 29.73
